Summary
CVS Health Corporation (CVS) has filed a Current Report (8-K) on October 28, 2025, primarily to announce its financial results for the third quarter ended September 30, 2025. The company issued a press release on October 29, 2025, detailing these results, which is furnished as an exhibit to this filing. Investors should refer to this press release (Exhibit 99.1) for specific financial performance data, including revenues, earnings, and any segment-specific updates. While this 8-K filing itself does not contain the detailed financial figures, it serves as the official notification of their release. The furnished press release will be crucial for understanding CVS Health's operational and financial condition as of the reporting period. Investors are advised to review the press release for forward-looking statements, management's commentary on performance, and any updated guidance provided by the company. It is important to note that the information furnished under Item 2.02 is not deemed "filed" for purposes of Section 18 of the Exchange Act, meaning it does not carry the same legal implications as a formally filed report, but it is still a key disclosure for market participants.
Key Highlights
- 1CVS Health announced its third-quarter 2025 financial results via press release on October 29, 2025.
- 2The 8-K filing's primary purpose is to furnish this press release (Exhibit 99.1) under Item 2.02.
- 3Investors need to consult the furnished press release for specific financial performance data and operational updates for the quarter ended September 30, 2025.
- 4The filing includes the standard Cover Page Interactive Data File in XBRL format.
- 5Information furnished under Item 2.02 is generally not considered 'filed' for Section 18 liability purposes.